Hamza Drabu

Head of Health

London

Hamza Drabu is a commercial lawyer who specialises in advising commissioners and providers of health and social care services on commercial, contractual and public law issues.
Links
Successfully added
Failed to add

About Hamza

Bio
  • Biography

    Hamza specialises in commercial law, regulatory and governance matters. Hamza has advised on a number of projects with an international focus, including advising clients on inward investment projects into the UK, as well as leading on multi-jurisdictional projects alongside an international team of lawyers.

    He has over 12 years’ experience advising clients in the health and social care sector. His key clients include medtech and digital health companies, NHS commissioners and providers, independent operators of health and social care, at-scale providers of primary care services and voluntary sector organisations. He has advised on a broad range of matters, including major strategic procurements, public/private sector collaborations, mergers and acquisitions, regulatory due diligence and highly regulated commercial contracts in the health and social care sector.

    Hamza’s experience in advising health and social care sector clients means that he is expert in understanding the regulatory framework that they operate within; his commercial advice is provided in that context.

    Relevant experience includes advising:

    • A range of new market entrants seeking to establish digital health solutions in the NHS on commercial, regulatory and strategic matters.
    • A national commissioner on the commercial and procurement aspects in a competitive process for a major strategic procurement process to roll out medical technology across the country, focussed on better access to cancer diagnostics.
    • A medtech company on its contractual arrangements for collaboration with NHS Trusts/FTs for the provision of capital equipment.
    • Various integrated care systems in the NHS seeking to integrate commissioning governance, and allow for a more co-ordinated provision of health and social care services.

    Hamza is recognised by the Legal 500 as a “Next Generation Partner”, and is described as “The ‘quick thinking’ Hamza Drabu who ‘understands clients’ needs and designs creative solutions to complex problems’.”

    Hamza featured in the 2,000 Days Project, setting out practical ways to overcome legal barriers in order to help the NHS reform health and social care provision. The 2,000 Days Project was reported on in The Guardian.

Sector Expertise
  • Health and Social Care

Service Expertise
  • Intellectual Property

  • Corporate Health

  • Public law and judicial review

  • Health and Social Care Regulatory

  • Healthcare Regulatory

  • Governance and Compliance in Healthcare

  • Data, Privacy and Cyber in Health

  • Commercial Health

Office Location

London Skyline

London

  • 25 Walbrook
  • London
  • EC4N 8AF

+44 (0) 207 242 1011

View our office

Articles

There are no matching articles, please try a different filter.

Health and Social Care

7 min read

AI in healthcare – MHRA's strategy and the AI Airlock

Health and Social Care

1 min read

Health Adviser – Issue 24: NextGen Health: Tomorrow's Care, Today's Innovations

News

1 min read

DAC Beachcroft launches Health Adviser: ‘NextGen Health: Tomorrow’s Care, Today’s Innovations'

Health and Social Care

5 min read

Tackling Health Disparities – the Independent Review of Equity in Medical Devices

News

2 min read

DAC Beachcroft advises BHSCT on multi-million pound medical equipment project

News

2 min read

DAC Beachcroft advises Brainkind on acquisition of neurological care services

MedTech and Digital Health

9 min read

Boosting Life Sciences through innovation and regulation

News

2 min read

DAC Beachcroft makes senior appointment to strengthen health and social care practice

News

3 min read

DAC Beachcroft expands its health real estate practice with double partner hire

Health and Social Care

7 Min Read

Next step in medical device reform – new GB post-market surveillance rules published